Daratumumab monotherapy in relapsed and refractory multiple myeloma patients with severely compromised forced expiratory volume in one second

Blood Res. 2022 Mar 31;57(1):76-80. doi: 10.5045/br.2022.2021183.
No abstract available

Publication types

  • Letter